CognitMarket market news, portfolio research, and investor insights

Your market command center

Research the market. Understand your portfolio. Act with confidence.

Turn market-moving news into a focused daily view of the companies, portfolios, and ideas you care about.

Login
Create my free account
Free to start · No card required

Top Stories

The developments most likely to shape today’s market conversation.
NiSource signs 20-year power deal with Microsoft for Indiana campus
Company News

NiSource signs 20-year power deal with Microsoft for Indiana campus

INVESTING.COM

NiSource Inc. (NI) has announced a 20-year energy agreement with Microsoft to supply approximately 1,100 MW of generation resources to a northwest Indiana data center campus, with service expected to begin in 2028.

Under the agreement, Microsoft will fully fund all generation and transmission infrastructure required to serve its load through NiSource’s generation subsidiary, NiSource Generation Company LLC (GenCo). The structure is designed to shield existing Northern Indiana Public Service Company LLC (NIPSCO) electric customers from incremental costs associated with serving the data center.

NiSource said the deal expands projected savings for existing NIPSCO electric customers to approximately $1.75 billion over the life of its data center contracts, up from a previously disclosed $1.4 billion figure. The company said this equates to as much as $140 per customer annually.

In connection with the agreement, GenCo has contracted 600 MW of battery storage under a long-term tolling agr

Omeros shares slide following European regulatory setback for Narsoplimab
Company News

Omeros shares slide following European regulatory setback for Narsoplimab

STREETINSIDER.COM

Investing.com -- Shares of Omeros Corporation (NASDAQ: OMER) retreated 4% in Friday morning trading after the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) maintained a negative opinion on the marketing authorization application for its drug, narsoplimab.

Following a formal re-examination, the CHMP rejected narsoplimab as a treatment for hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA), reaffirming its initial negative stance from June 2026.

The regulatory decision follows a contested review process. As part of the re-examination, the CHMP convened an eight-member ad hoc expert group comprising hematologists, statisticians, transplant physicians, and patient representatives. According to the CHMP’s final minutes, this expert group recommended that external specialists review individual patient-level data to better understand factors driving treatment response and survival. While Omeros had submitted substantia

City Therapeutics surges in market debut after upsizing $200M IPO
Company News

City Therapeutics surges in market debut after upsizing $200M IPO

STREETINSIDER.COM

City Therapeutics Inc (NASDAQ: CTY) made a strong Nasdaq debut on Friday, surging 28% after raising $200 million in an upsized initial public offering. The Cambridge, Massachusetts-based biotechnology firm sold 11.11 million shares at $18.00 each, the midpoint of its expected target range, after expanding the offering from an initial plan of 9.72 million shares.

Trading opened at $23.00 under the ticker symbol "CTY," pushing the company’s valuation to approximately $1.19 billion based on total outstanding shares. The offering, backed by prominent healthcare investors Arch Venture Partners and Fidelity Management & Research, underscored robust institutional demand for early-stage RNA interference developers.

The clinical-stage biotech granted underwriters a 30-day option to buy up to an additional 1.67 million shares at the IPO price. Proceeds are expected to fund the advancement of City’s proprietary RNAi platform and its lead therapeutic pipelines, led by joint book-running managers

Europe’s answer to SpaceX pops 19% as Ukraine’s Starshield limits raise concerns
Company News

Europe’s answer to SpaceX pops 19% as Ukraine’s Starshield limits raise concerns

CNBC.COM

In this article

Shares of French Satellite Group Eutelsat soared this week as SpaceX’s Starshield drew criticism after the Ukrainian military’s access to its systems was suddenly restricted.

Earlier this week, tensions rose between the U.S. and Ukraine after Kyiv accused Elon Musk’s SpaceX of imposing new restrictions on its military-grade Starlink internet service without warning, curbing connectivity and limiting Ukraine’s ability to defend itself against Russian attacks.

Ukraine’s President Volodymyr Zelenskyy criticized the U.S., saying “Starlink was switched off” in the middle of the night, preventing Ukrainian drones from intercepting Russian attacks, and ultimately contributing to civilian deaths.

“They knew what they did,” Zelenskyy said. “It’s not about attack. It’s also about defending the lives… People were killed because not enough destroying, not enough interceptors, including interceptors with Starlink, which didn’t work.”

SpaceX CEO Elon Musk responded by shifting b

Fox Factory replaces CEO, cuts fiscal 2026 outlook on weak Q3
Company News

Fox Factory replaces CEO, cuts fiscal 2026 outlook on weak Q3

INVESTING.COM

Fox Factory Holding Corp. (FOXF) announced on Oct. 16, 2026, that its board of directors has appointed independent director Douglas Grimm as interim chief executive officer, effective immediately. Mike Dennison stepped down as CEO and as a board member on the same date.

The company has retained executive search firm Heidrick & Struggles to identify a permanent CEO. The search will be led by board Chair Jean Hlay and directors Tom Duncan and Grimm, who is not a candidate for the permanent role. Alan Bazaar will succeed Grimm as chair of the Audit Committee.

Grimm has more than 40 years of experience in the automotive and industrial sectors. He currently serves as chairman of Blue Bird Corporation (BLBD) and as a board member of Lucid Group, Inc. (LCID).

Alongside the leadership change, Fox Factory reported preliminary third-quarter fiscal 2026 results that fell short of its own guidance. Net sales for the quarter ended Oct. 2, 2026, are expected to range from $336 million to $340 mil

NVIDIA Is The Foundational AI Company To Own
Analyst & Opinion

NVIDIA Is The Foundational AI Company To Own

FINANCE.YAHOO.COM

Motley Fool Asset Management's Bill Mann sees long-term potential in AI, but says investors should weigh debt, cash-flow timing, and business quality before treating a sell-off as a bargain.

Uh, I think that one of the key ways to do it is to look at the companies that seem foundational. You know, an Nvidia for example, is a foundational company. They are they are involved in the build out, for example, and I don't really see that as being something that, you know, that that is going to change.

There are there are other components of the market where again, you're starting to see these companies take huge amounts of debt on. So they might be foundational companies, but they also might be creating a mismatch for themselves.

And and there I'm thinking about the Metas of the world and the and the Alphabetts of the world, which are great companies and I have no problem having exposure to them, but, you know, debt is an entirely different set of factors than equity just because of the of

1 / 6

For You

Personalize this briefing around the investments you care about.

Follow the market through your own lens.

Create a free account to bring watchlist updates, portfolios, and Autopilot status into this briefing.

Trending now

Top portfolios

From the Community

Recent questions, research, and investing ideas from members.

The U.S. fiscal year 2026 concluded with a budget deficit of nearly $2 trillion ($1.992T), marking a 12% increase from the prior year. This is the third-highest annual deficit in U.S. history, excluding pandemic stimulus years.

Key figures:

  • Total Deficit: $1.992 trillion (vs. $1.775T in FY2025)
  • Spending Drivers: Social Security ($1.7T), Medicare ($1.1T), and net interest payments (over $1T) were major contributors.
  • Revenue: Individual income taxes rose 7% to over $2.8T, while corporate income tax receipts fell by $70B .

The persistent deficit adds to concerns over the nation's financial health, previously reflected in rising Treasury yields.

U.S. budget deficit swells to almost $2 trillion for fiscal 2026, up 12% in a single year

U.S. budget deficit swells to almost $2 trillion for fiscal 2026, up 12% in a single year

CNBC.COMOct 16, 6:00 PM UTC
0

Eli Lilly's oral weight-loss drug, Foundayo, has received a recommendation for approval from the European Medicines Agency (EMA). This marks the second oral obesity drug to gain EU backing, following Novo Nordisk's Wegovy pill .

Key points:

  • EMA's committee recommended Foundayo for weight management and type 2 diabetes in adults .
  • Patients in trials lost up to 11% of body weight .
  • Foundayo is already launched in the US (April) and UK (August), generating $98M in Q2 sales .
  • Lilly touts Foundayo's convenience, as it can be taken without food/water restrictions, unlike Wegovy .

This approval positions Lilly to compete in a market projected to exceed $100 billion by 2030, intensifying the race with Novo Nordisk for market share .

Eli Lilly’s weight-loss pill wins EU drug regulator’s backing

Eli Lilly’s weight-loss pill wins EU drug regulator’s backing

INVESTING.COMOct 16, 1:25 PM UTC
0

Fox Factory Holding Corp. (FOXF) announced a leadership change and significantly lowered its fiscal 2026 outlook after preliminary Q3 results fell short of guidance.

Key points:

  • CEO Mike Dennison stepped down, replaced by interim CEO Douglas Grimm .
  • Q3 net sales expected at $336M-$340M, below guidance of $355M-$380M.
  • Adjusted EBITDA projected at $38M-$42M, missing guidance of $46M-$54M.
  • Full FY26 net sales guidance cut to $1.35B-$1.38B (from $1.42B-$1.47B).
  • Full FY26 adjusted EBITDA guidance slashed to $140M-$150M (from $176M-$196M).

The company cited lower sales/margins at Marucci Sports, supply disruptions, operational challenges, and softer bike sales for the shortfall .

Fox Factory replaces CEO, cuts fiscal 2026 outlook on weak Q3

Fox Factory replaces CEO, cuts fiscal 2026 outlook on weak Q3

INVESTING.COMOct 16, 12:22 PM UTC
0

Tesla shares surged nearly 5% in premarket trading after CEO Elon Musk unveiled the new Roadster model with a live demonstration, targeting 2028 production . This comes as broader AI trade concerns continue, with 'neocloud' company CoreWeave's debt showing distress . The S&P 500 and Nasdaq Composite are still on track for weekly declines .

Premarket movers: Tesla jumps; Strategy falls on MSCI index threat

Premarket movers: Tesla jumps; Strategy falls on MSCI index threat

INVESTING.COMOct 16, 10:58 AM UTC
0

The White House reportedly directed SpaceX to restrict its Starshield satellite service for Ukraine's military, impacting battlefield communications and drone operations . This move comes amidst President Trump's push for Kyiv to halt strikes on Russian refineries and a diesel supply deal with Russia, raising questions about U.S. policy and potential geopolitical shifts. The Pentagon is Starshield's largest customer .

White House ordered SpaceX to limit Ukraine satellite service, Reuters reports

White House ordered SpaceX to limit Ukraine satellite service, Reuters reports

INVESTING.COMOct 16, 12:15 AM UTC
0

A notable sector rotation is underway as investors pull back from high-flying tech stocks like Nvidia (NVDA) and Amazon (AMZN), which saw declines. This shift is boosting defensive consumer-centric names and healthcare stocks .

Sportswear giant Nike (NKE) jumped 5%, leading gains on the Dow Jones Industrial Average. Other beneficiaries include Sherwin-Williams (SHW), Home Depot (HD), Walmart (WMT), McDonald’s (MCD), UnitedHealth Group (UNH), and Amgen (AMGN), all climbing . Concerns over AI financing and competition are cited as drivers for this rotation into more stable sectors .

These Consumer Stocks Are Getting a Lift as Investors Rotate Out of Tech

These Consumer Stocks Are Getting a Lift as Investors Rotate Out of Tech

INVESTOPEDIA.COMOct 15, 7:48 PM UTC
1

S&P Global Ratings has revised its credit outlook for Prudential Financial (PRU) to Negative from Stable, citing operational and regulatory challenges in Japan. The downgrade follows business suspension orders from Japan's Financial Services Agency due to sales misconduct. S&P projects a pre-tax financial drag of $600M in 2026, rising to $675M-$725M in 2027. This raises concerns about holding company liquidity, as Japan historically contributed nearly 30% of PRU's holding company dividends.

S&P revises Prudential’s outlook to negative on Japan headwinds

S&P revises Prudential’s outlook to negative on Japan headwinds

STREETINSIDER.COMOct 15, 4:30 PM UTC
4

FMC Corporation (NYSE: FMC) shares tumbled 35% after the agricultural sciences company slashed its Q3 2026 guidance. The company now projects Q3 revenue between $65M-$125M and an adjusted EBITDA loss of $510M-$565M, reflecting a $625M-$675M impact from aggressive commercial actions .

Key points:

  • Demand Weakness: Weaker-than-expected demand and elevated inventory of higher-priced products held by channel partners .
  • Pricing Pressure: Rapid market price declines due to intensifying generic competition .
  • Strategic Overhaul: FMC is implementing price reductions and restructuring its U.S. pricing and sales model to address inventory bottlenecks .

This profit warning signals significant headwinds in the agricultural chemicals sector.

FMC tumbles 35% after slashing Q3 outlook over weak demand and inventory issues

FMC tumbles 35% after slashing Q3 outlook over weak demand and inventory issues

STREETINSIDER.COMOct 15, 12:16 PM UTC
3

U.S. Producer Price Index (PPI) for final demand jumped 1.3% month-over-month in September, significantly exceeding expectations of 0.6%. This marks the largest increase in 4.5 years, driven primarily by a record 2.6% surge in goods costs, with gasoline prices soaring 20.3% .

The year-over-year PPI rose to 6.3% from 5.6%, surpassing the 5.3% forecast. This hot inflation data, following yesterday's higher-than-expected CPI, intensifies concerns about persistent inflationary pressures and could influence the Federal Reserve's interest rate decisions .

U.S. producer prices rise by 1.3% month-on-month in September

U.S. producer prices rise by 1.3% month-on-month in September

STREETINSIDER.COMOct 15, 12:40 PM UTC
3

The sell-off in AI and semiconductor stocks has intensified, wiping over $1 trillion from market caps this week. Nasdaq futures are down >1% as investors fret over higher interest rates and debt concerns impacting AI infrastructure funding .

Key points:

  • Global Impact: Nvidia (-1.8%), Micron (-4.4%), AMD (-3.5%), TSMC (-1.81%), ASML (-6.6%), and other major chipmakers and AI-related firms are experiencing significant declines .
  • Macro Headwinds: Hotter-than-expected inflation data fuels expectations of more Fed rate hikes, increasing borrowing costs for capital-intensive AI investments .
  • Debt Concerns: Heavily indebted data center operator CoreWeave fell 4.5% in premarket, with its bonds under pressure .
  • Guidance: TSMC struck a cautious note for 2027 due to macroeconomic uncertainties .

This deepening rout signals growing investor anxiety over the sustainability of AI sector valuations amid a tightening monetary environment.

Nvidia, AMD, Micron fall as AI stocks continue $1 trillion selloff amid mounting concerns

Nvidia, AMD, Micron fall as AI stocks continue $1 trillion selloff amid mounting concerns

CNBC.COMOct 15, 8:11 AM UTC
Nasdaq futures dive 1% as AI rout deepens on debt concerns

Nasdaq futures dive 1% as AI rout deepens on debt concerns

INVESTING.COMOct 15, 8:24 AM UTC
1 / 2
4